Found 4 matching trials
Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer
PHASE3This study aims to conduct a randomized controlled clinical trial to compar...
Status
Active Not Recruiting
Location
breast cancer institute of Fudan University Cancer Hospital, shanghai, shanghai
Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC
PHASE2This study is a single center, randomized controlled, prospective phase II ...
Location
the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.
PHASE2This study is a single-arm, multicenter, phase II exploratory trial. The pu...
Cetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCC
PHASE2This study is the first clinical study in PD-1 resistant patients with head...
Location
the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine